Axsome Therapeutics, INC. (AXSM) — 8-K Filings

All 8-K filings from Axsome Therapeutics, INC.. Browse 26 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (26)

Axsome Therapeutics Files 8-K — Dec 31, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on December 31, 2025, reporting on other events and financial statements. The filing details the company's corporate info
Axsome Therapeutics Files 8-K — Aug 20, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on August 20, 2025, reporting other events and financial statements as of August 19, 2025. The filing does not detail spe
Axsome Therapeutics Files 8-K — Jun 10, 2025 Risk: low
On June 10, 2025, Axsome Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicatin
Axsome Therapeutics Files 8-K — Jun 9, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on June 9, 2025, reporting other events and financial statements. The filing does not contain specific details on new eve
Axsome Therapeutics Files 8-K — May 27, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on May 27, 2025, reporting other events and financial statements. The filing does not contain specific details on new eve
Axsome Therapeutics Files 8-K with Key Agreements and Sales — May 13, 2025 Risk: medium
On May 8, 2025, Axsome Therapeutics, Inc. entered into a material definitive agreement and simultaneously terminated another. The company also created a direct
Axsome Therapeutics Files 8-K — Apr 1, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on April 1, 2025, reporting other events and financial statements. The filing does not contain specific financial figures
Axsome Therapeutics Files 8-K Report — Mar 25, 2025 Risk: low
On March 25, 2025, Axsome Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicati
Axsome Therapeutics Files 8-K — Mar 5, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on March 5, 2025, to report other events and financial statements. The filing does not contain specific details about the
Axsome Therapeutics Files 8-K — Mar 3, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on March 3, 2025, to report other events and financial statements. The filing does not contain specific financial figures
Axsome Therapeutics Files 8-K Report — Feb 10, 2025 Risk: low
On February 10, 2025, Axsome Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indic
Axsome Therapeutics Files 8-K Report — Jan 31, 2025 Risk: low
On January 30, 2025, Axsome Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indica
Axsome Therapeutics Files 8-K on Financials and Events — Jan 13, 2025 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition, as well as other events. The filing
Axsome Therapeutics Files 8-K — Dec 30, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on December 30, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain speci
Axsome Therapeutics Files 8-K — Nov 26, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on November 26, 2024, to report other events and financial statements. The filing does not contain specific details about
Axsome Therapeutics Enters Material Definitive Agreement — Oct 1, 2024 Risk: medium
On September 30, 2024, Axsome Therapeutics, Inc. entered into a material definitive agreement. The filing does not provide specific details on the agreement or
Axsome Therapeutics Files 8-K — Sep 4, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on September 4, 2024, reporting other events and financial statements. The filing details the company's principal executi
Axsome Therapeutics Files 8-K — Aug 21, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on August 21, 2024, reporting other events and financial statements/exhibits. The filing details the company's principal
Axsome Therapeutics Files 8-K for Shareholder Votes & Exhibits — Jun 11, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on June 7, 2024, to report on matters submitted to a vote of security holders and to file financial statements and exhibi
Axsome Therapeutics Files 8-K — Jun 5, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on June 5, 2024, to report other events and financial statements. The filing does not contain specific details about new
Axsome Therapeutics Files 8-K — Apr 1, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on April 1, 2024, reporting an event that occurred on March 28, 2024. The filing primarily concerns financial statements
Axsome Therapeutics Files 8-K — Mar 25, 2024 Risk: low
On March 25, 2024, Axsome Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update r
Axsome Therapeutics Files 8-K Report — Mar 19, 2024 Risk: low
On March 19, 2024, Axsome Therapeutics, Inc. filed an 8-K report. The filing primarily serves as a notification of other events and the inclusion of financial s
Axsome Therapeutics Files 8-K on Financial Condition — Feb 20, 2024 Risk: low
Axsome Therapeutics, Inc. filed an 8-K on February 20, 2024, to report on its results of operations and financial condition. The filing, under SEC File Number 0
Axsome Therapeutics Files 8-K for 'Other Events' & Financial Exhibits — Jan 8, 2024
Axsome Therapeutics, Inc. filed an 8-K on January 8, 2024, to report an "Other Event" and provide "Financial Statements and Exhibits." This filing, under SEC Fi
Axsome Therapeutics Files 8-K on Financial Condition & Other Events — Jan 4, 2024
Axsome Therapeutics, Inc. filed an 8-K on January 4, 2024, to report on "Results of Operations and Financial Condition" and "Other Events." This filing indicate

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX